Puig-Barberà J, Mira-Iglesias A, Tortajada-Girbés M, López-Labrador F X, Librero-López J, Díez-Domingo J, Carballido-Fernández M, Carratalá-Munuera C, Correcher-Medina P, Gil-Guillén V, Limón-Ramírez R, Mollar-Maseres J, Otero-Reigada M C, Schwarz H
FISABIO-Salud Pública, 46020 Valencia, Spain; Centro de Salud Pública de Castellón, 12003 Castellón, Spain.
FISABIO-Salud Pública, 46020 Valencia, Spain.
Vaccine. 2017 Oct 13;35(43):5799-5807. doi: 10.1016/j.vaccine.2017.09.035. Epub 2017 Sep 20.
Concerns have been raised about intraseasonal waning of the protection conferred by influenza vaccination.
During four influenza seasons, we consecutively recruited individuals aged 18years or older who had received seasonal influenza vaccine and were subsequently admitted to the hospital for influenza infection, asassessed by reverse transcription polymerase chain reaction. We estimated the adjusted odds ratio (aOR) of influenza infection by date of vaccination, defined by tertiles, as early, intermediate or late vaccination. We used a test-negative approach with early vaccination as reference to estimate the aOR of hospital admission with influenza among late vaccinees. We conducted sensitivity analyses by means of conditional logistic regression, Cox proportional hazards regression, and using days between vaccination and hospital admission rather than vaccination date.
Among 3615 admitted vaccinees, 822 (23%) were positive for influenza. We observed a lower risk of influenza among late vaccinees during the 2011/2012 and 2014/2015A(H3N2)-dominant seasons: aOR=0.68 (95% CI: 0.47-1.00) and 0.69 (95% CI: 0.50-0.95). We found no differences in the risk of admission with influenza among late versus early vaccinees in the 2012/2013A(H1N1)pdm09-dominant or 2013/2014B/Yamagata lineage-dominant seasons: aOR=1.18 (95% CI: 0.58-2.41) and 0.98 (95% CI: 0.56-1.72). When we restricted our analysis to individuals aged 65years or older, we found a statistically significant lower risk of admission with influenza among late vaccinees during the 2011/2012 and 2014/2015A(H3N2)-dominant seasons: aOR=0.61 (95% CI: 0.41-0.91) and 0.69 (95% CI: 0.49-0.96). We observed 39% (95% CI: 9-59%) and 31% (95% CI: 5-50%) waning of vaccine effectiveness among participants aged 65years or older during the two A(H3N2)-dominant seasons. Similar results were obtained in the sensitivity analyses.
Waning of vaccine protection was observed among individuals aged 65years old or over in two A(H3N2)-dominant influenza seasons.
流感疫苗接种所提供的保护在季节内减弱的问题已引起关注。
在四个流感季节中,我们连续招募了18岁及以上接种过季节性流感疫苗且随后因流感感染入院的个体,通过逆转录聚合酶链反应进行评估。我们根据接种日期将其分为三分位数,即早期、中期或晚期接种,估计流感感染的调整优势比(aOR)。我们采用以早期接种为对照的检测阴性方法,估计晚期接种者中因流感入院的aOR。我们通过条件逻辑回归、Cox比例风险回归以及使用接种与入院之间的天数而非接种日期进行敏感性分析。
在3615名入院的接种者中,822人(23%)流感检测呈阳性。在2011/2012年和2014/2015年以A(H3N2)为主的季节中,我们观察到晚期接种者患流感的风险较低:aOR = 0.68(95%置信区间:0.47 - 1.00)和0.69(95%置信区间:0.50 - 0.95)。在2012/2013年以A(H1N1)pdm09为主或2013/2014年以B/ Yamagata谱系为主导的季节中,我们发现晚期与早期接种者因流感入院的风险没有差异:aOR = 1.18(95%置信区间:0.58 - 2.41)和0.98(95%置信区间:0.56 - 1.72)。当我们将分析限制在65岁及以上的个体时,我们发现在2011/2012年和2014/2015年以A(H3N2)为主的季节中,晚期接种者因流感入院的风险在统计学上显著较低:aOR = 0.61(95%置信区间:0.41 - 0.91)和0.69(95%置信区间:0.49 - 0.96)。在两个以A(H3N2)为主的季节中,我们观察到65岁及以上参与者的疫苗效力分别下降了39%(95%置信区间:9 - 59%)和31%(95%置信区间:5 - 50%)敏感性分析也得到了类似结果。
在两个以A(H3N2)为主导流感季节中,65岁及以上个体中观察到了疫苗保护作用的减弱。